The European Bioanalysis Forum
EBF was founded in 2006 at the initiative of 12 pharmaceutical companies, all of them having bioanalytical lab activities in Europe. The goal of bringing these companies together was to implement a platform for discussions of science, day-to-day procedures, business tools, technologies and last but not least regulatory issues. EBF currently hosts two types of internally-organized meetings:
Working group meetings:
Twice a year EBF brings together all member companies (currently 26) to discuss subjects well prepared in advance. The topics range from procedural to regulatory often resulting in internal benchmarking or surveys. This year, EBF will also start a subgroup "Macromolecules", to provide a platform for scientific exchange and harmonization of specific aspects for the bioanalysis of large molecules.
All member companies can assign one representative to these closed meetings.
Open meetings (symposium):
EBF organizes annual symposia to involve the bioanalytical community (pharma, academia, CRO, instrument providers, regulatory, etc.).
It is the intention of the EBF to inform our business partners about the agreements achieved and to open the forum for challenging procedures or techniques as well as for new regulatory requirements.
EBF has also reached out to participate in international scientific meetings representing the bioanalytical voice of the European Pharma industry. EBF intends to stimulate further harmonization of industry practices in bioanalysis, to bring a common understanding of the interpretation of regulatory issues and more clarity to the implementation of procedures in order to achieve best practices in the world of bioanalysis. Selective examples of EBF's active participation are: 2008 AAPS/FDA meeting, 2007 and 2008 Boston APA meeting and 2009 AAPS/NBC.
Join us on 2nd, 3rd and 4th December 2009 for the 2nd Open Annual Symposium.
or more information about the EBF please contact contact@bioanalysis-forum.com